Cargando…

Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis

The European Medicines Agency has approved a multicomponent serogroup B meningococcal vaccine (Bexsero®) for use in individuals of 2 months of age and older. A cost-effectiveness analysis (CEA) from the societal and Italian National Health Service perspectives was performed in order to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gasparini, Roberto, Landa, Paolo, Amicizia, Daniela, Icardi, Giancarlo, Ricciardi, Walter, de Waure, Chiara, Tanfani, Elena, Bonanni, Paolo, Lucioni, Carlo, Testi, Angela, Panatto, Donatella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2016
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994748/ https://www.ncbi.nlm.nih.gov/pubmed/27163398 http://dx.doi.org/10.1080/21645515.2016.1160177

Ejemplares similares

The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
por: Semchenko, Evgeny A, et al.
Publicado: (2019)

Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes
por: Domnich, Alexander, et al.
Publicado: (2015)

Meningococcal B vaccination strategies and their practical application in Italy
por: GASPARINI, R., et al.
Publicado: (2015)

Crystal structures of human Fabs targeting the Bexsero meningococcal vaccine antigen NHBA
por: Maritan, Martina, et al.
Publicado: (2017)

Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence
por: Boccalini, Sara, et al.
Publicado: (2020)

Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention
por: Panatto, Donatella, et al.
Publicado: (2016)

New versus old meningococcal Group B vaccines: How the new ones may benefit infants & toddlers
por: Panatto, D., et al.
Publicado: (2013)

Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment
por: de Waure, Chiara, et al.
Publicado: (2019)

A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation
por: Panatto, Donatella, et al.
Publicado: (2018)

An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional Campaign
por: Panatto, Donatella, et al.
Publicado: (2016)

Influenza epidemiology in Italy two years after the 2009–2010 pandemic: Need to improve vaccination coverage
por: Gasparini, Roberto, et al.
Publicado: (2013)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
por: Hong, Eva, et al.
Publicado: (2016)

The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment
por: Calabrò, Giovanna Elisa, et al.
Publicado: (2022)

Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain
por: Pérez-Trallero, Emilio, et al.
Publicado: (2014)

Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme
por: Tirani, Marcello, et al.
Publicado: (2015)

Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population
por: Capri, Stefano, et al.
Publicado: (2018)

Product review on the IMD serogroup B vaccine Bexsero®
por: Deghmane, Ala-Eddine, et al.
Publicado: (2022)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine
por: Domnich, Alexander, et al.
Publicado: (2023)

Distribution of Bexsero® Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation
por: Brehony, Carina, et al.
Publicado: (2016)

Influenza vaccination coverage in the elderly and socio-economic inequalities in Italy
por: PANATTO, D., et al.
Publicado: (2019)

Vaccination against Tick-Borne Encephalitis (TBE) in Italy: Still a Long Way to Go
por: Panatto, Donatella, et al.
Publicado: (2022)

Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies
por: Gasparini, R., et al.
Publicado: (2016)

Assessing Ebola-related web search behaviour: insights and implications from an analytical study of Google Trends-based query volumes
por: Alicino, Cristiano, et al.
Publicado: (2015)

COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy
por: Domnich, Alexander, et al.
Publicado: (2022)

Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V(®) and Fluad(®)) in preventing hospitalization for influenza and pneumonia in the elderly: A matched case-control study
por: Gasparini, Roberto, et al.
Publicado: (2013)

Modelling the cost-effectiveness of catch-up ‘MenB’ (Bexsero) vaccination in England
por: Christensen, Hannah, et al.
Publicado: (2017)

Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy?
por: Panatto, Donatella, et al.
Publicado: (2013)

The "urban myth" of the association between neurological disorders and vaccinations
por: GASPARINI, R., et al.
Publicado: (2015)

Effect of the 2020/21 season influenza vaccine on SARS-CoV-2 infection in a cohort of Italian healthcare workers
por: Domnich, Alexander, et al.
Publicado: (2022)

Increasing Influenza Vaccination Uptake by Sending Reminders: A Representative Cross-Sectional Study on the Preferences of Italian Adults
por: Domnich, Alexander, et al.
Publicado: (2023)

Influenza Vaccination in Italian Healthcare Workers (2018–2019 Season): Strengths and Weaknesses. Results of a Cohort Study in Two Large Italian Hospitals
por: Panatto, Donatella, et al.
Publicado: (2020)

How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project
por: GASPARINI, R., et al.
Publicado: (2015)

Acceptance of COVID-19 and Influenza Vaccine Co-Administration: Insights from a Representative Italian Survey
por: Domnich, Alexander, et al.
Publicado: (2022)

Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study
por: Christensen, Hannah, et al.
Publicado: (2014)

Strengthening the Evidence-Based Approach to Guiding Effective Influenza Vaccination Policies
por: Calabrò, Giovanna Elisa, et al.
Publicado: (2020)

Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines
por: Amicizia, Daniela, et al.
Publicado: (2013)

Surveillance of Severe Acute Respiratory Infection and Influenza Vaccine Effectiveness among Hospitalized Italian Adults, 2021/22 Season
por: Panatto, Donatella, et al.
Publicado: (2022)

Age- and risk-related appropriateness of the use of available influenza vaccines in the Italian elderly population is advantageous: results from a budget impact analysis
por: BARBIERI, M., et al.
Publicado: (2017)

Overview of the impact of Typhoid and Paratyphoid fever. Utility of Ty21a vaccine (Vivotif®)
por: Amicizia, D., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d79pgqe1itrp1dllih1nls653o